Learn More
Medchemexpress LLC Eltrombopag Olamine | 496775-62-3 | C29H36N6O6 | 50 MG

Supplier: Medchemexpress LLC HY15306A50MG
Eltrombopag Olamine is an orally active, nonpeptide agonist of the thrombopoietin receptor, possessing thrombopoietic activity. It has been researched for treating low blood platelet counts associated with chronic immune thrombocytopenia and for cardiovascular research. It also exhibits strong inhibitory effects against multidrug-resistant *Staphylococcus aureus* and can induce apoptosis in hepatocellular carcinoma cells.
- Orally active thrombopoietin receptor nonpeptide agonist
- Used in research for low blood platelet counts associated with chronic immune thrombocytopenia
- Relevant for cardiovascular research
- Exhibits strong inhibitory effects against multidrug-resistant *Staphylococcus aureus*
- Induces apoptosis in hepatocellular carcinoma (HCC) cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.